Similarly, the frequency of most myeloid cells was elevated in TC-1/dCD80-1- compared with that in TC-1-induced tumors (Figure 5C), such as tumor-associated macrophages (TAMs; CD45+, CD11b+, Ly6G−, F4/80+, SSClo), classical dendritic cells (cDCs; CD45+, CD11c+, F4/80−, Ly6C−, CD317−), plasmacytoid dendritic cells (pDCs; CD45+, CD11c+, CD11b−, F4/80−, Ly6C+, CD317+), myeloid-derived suppressor cells (MDSCs; CD45+, CD11b+, Ly6G−, F4/80−, Ly6Chi), and tumor-associated neutrophils (TANs; CD45+, CD11b+, CD11c−, Ly6Cint, Ly6G+). This evidence concerns the gene BST2 and neoplasm.